Dr. Nishi Prabdial-Sing

Nishi Prabdial-Sing is a South African public health researcher whose work centers on viral hepatitis epidemiology, surveillance, and elimination strategies. Affiliated with national laboratory and public health surveillance initiatives, contributions bridge laboratory data analytics with policy-relevant insights, supporting national and global efforts aligned with WHO elimination targets.

Research focuses strongly on hepatitis B in South Africa, including prevalence, incidence, chronicity, vertical transmission, and vaccination gaps. Analyses of national laboratory datasets have clarified disease burden patterns and informed recommendations on birth-dose vaccination and antenatal screening. Broader contributions to global modelling studies on hepatitis B and C have strengthened understanding of cascade of care and progress toward elimination.

Recent work extends to hepatitis A molecular epidemiology and outbreak detection, as well as immunity gap estimation for poliovirus, demonstrating expertise in surveillance systems, genotyping, and modelling. A Lancet Microbe review on HBV drug resistance highlights engagement in high-level global consultations, underscoring leadership in translating surveillance evidence into strategic public health action.